International audienceA total synthesis of (+)-brefeldin C (BFC) and two brefeldin A (BFA) analogues - (+)-nor-Me BFA and (+)-4-epi-nor-Me BFA - has been developed, Key features of the syntheses include desymmetrization of meso anhydrides, a Carreira reaction to control the absolute configuration at C4 of BFC, a Suzuki-Miyaura cross-coupling reaction to create the C11-C12 bond and a Yamaguchi reaction to form the 13-membered lactone ring
A new synthesis of (+)-brefeldin C featuring a Bolm desymmetrisation reaction, a B-alkyl Suzuki-Miyaura cross-coupling and a Carreira alkynylation reaction as the key steps is reported.Brefeldin A (BFA) 1 (Scheme 1) is a naturally occurring 16-membered macrolide antibiotic first isolated 1 from Penicillium decumbens and subsequently identified as a metabolite from several other ascomycetes sources. 2 BFA exhibits a diversity of biological activities, which include antiviral and antitumor effects. 3 BFA is also an important tool for cell biologists due to its dramatic effects on the structure and functioning of intracellular organelles, particularly the Golgi apparatus. 4 Therefore, BFA, and its direct biosynthetic precursor brefeldin C (BFC), offer promising opportunities for the development of structural analogs useful for biological evaluation and study of intracellular vesicular trafficking.Herein, we report a new synthesis of natural (+)-BFC featuring the construction and union of three principal fragments resulting from the sequential disconnection of the C1-O s-bond as well as the C3-C4 and C11-C12 sbonds of the macrocyclic lactone as outlined in Scheme 2.As depicted in Scheme 2 and Scheme 3, union of fragments 1 and 2 was envisaged via a palladium-mediated Balkyl Suzuki-Miyaura cross-coupling reaction. 5 We planned to synthesise fragment 1 (5) from acid-ester 6, the synthesis of which was already reported 6 through a desymmetrisation process of meso anhydride 7, whereas the synthesis of fragment 2 was envisaged via opening of commercially available (S)-2-methyl-oxirane with an organometallic species. After functional group transformation (ester to aldehyde), application of the recently developed Carreira protocol 7 for the enantioselective synthesis of propargylic alcohols was envisioned for the attachment of fragment 3 with concomitant control of the absolute configuration at C4.Our synthesis of fragment 1 (Scheme 4) thus commenced with the desymmetrisation reaction of anhydride 7 available in multi-gram quantities from b-keto ester 8 through a three-step sequence of known reactions (59% overall yield). 8 Applying the Bolm protocol 6 to 7 afforded acidester 6 in 99% yield and with 94% ee, in complete agreement with the reported data. To establish the future C5 chiral centre of BFC with proper stereochemistry, acidester 6 was cleanly epimerised to 9 upon treatment with potassium tert-butoxide in THF (92% yield). Chemoselective acid to aldehyde transformation was best accomplished in a two-step sequence (BH 3 overreduction to an alcohol, followed by oxidation under Swern conditions) to provide aldehyde-ester 10 in 58% overall yield. To complete the synthesis of 5 (fragment 1), aldehyde 10 was subjected to the conditions of the Takai reaction (excess chromium chloride in a 1:6 THF-dioxane mixture for 72 h) 9 to afford the vinylic iodide 5 in 75% isolated yield and in excellent selectivity (E:Z isomer ratio = 97:3).
The 2005 Spring Meeting of the Swiss Chemical Society was held at the University of Bern on March 10th, 2005. The one-day symposium was dedicated to recent advances in chemical biology and synthesis. The four speakers, Dennis P. Curran, Johann Mulzer, Scott Miller, and Samuel Danishefsky covered a wide range of modern organic chemistry emphasizing "the formidable power of chemical synthesis" (Danishefsky) to investigate biologically relevant problems.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.